Regression patterns of choroidal melanoma: After palladium-103 (103Pd) plaque brachytherapy

被引:12
作者
Maheshwari, Abhilasha [1 ]
Finger, Paul T. [1 ]
机构
[1] New York Eye Canc Ctr, 115 East 61st St,Suite 5B, New York, NY 10065 USA
关键词
Choroidal melanoma; regression; pigment; exudative; ultrasound; FACTOR BEVACIZUMAB AVASTIN; POSTERIOR UVEAL MELANOMA; PROTON-BEAM IRRADIATION; RADIATION-THERAPY; TUMOR-REGRESSION; RU-106; BRACHYTHERAPY; GAMMA-KNIFE; RADIOTHERAPY; RETINOPATHY; OUTCOMES;
D O I
10.1177/1120672118776146
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe the patterns of regression of choroidal melanoma after treatment with plaque brachytherapy. Methods: Retrospective interventional case series including 170 consecutive patients treated with Pd-103 eye plaque radiation for choroidal melanoma. Outcome measures were changes in tumor thickness, surface characteristics, tumor vascularity, ultrasonography, fluorescein angiography, optical coherence tomography, and histopathology. Results: The mean initial tumor thickness was 3.9 mm (median 2.8 mm; range 2-11.3 mm) that decreased to 1.7 mm (median 1.2 mm; range 0-7.1 mm) after plaque brachytherapy. On imaging, tumors were pigmented in 51% (n = 86/170), amelanotic in 10% (n = 17/170), and variably pigmented in 39% (n = 67/170). Tumor pigmentation increased in 64% (n = 106/166), decreased in 18% (n = 30/166), and was unchanged in 18% (n = 30/166). Of the 120 that demonstrated intrinsic vascularity, 10% (n = 12/120) had decreased tumor-related vascularity and 90% (n = 108/120) showed complete resolution. Subretinal fluid was present in 34% (n = 58/170) of eyes at presentation. Of them, 15% (9; n = 9/58) had persistent SRF at last follow-up. On ultrasound imaging, 88% (n = 149/170) tumors presented with low to moderate internal reflectivity of which 61% (n = 91/149) showed increased reflectivity on regression. We noted a crescendo-decrescendo fluctuation in the presence of orange pigment lipofuscin along with complete resolution of drusenoid retinal pigment epithelial detachments. In the entire series of 170 patients, there was 0.5% (1) failure of local control, 2% (4) secondary enucleations, and 6% (10) patients developing metastasis. Conclusion: Findings related to choroidal melanoma regression after Pd-103 plaque brachytherapy included decreased intrinsic tumor vascularity, decreased tumor-related subretinal fluid, increased pigmentation, specific changes in orange pigment lipofuscin and resolution of drusenoid retinal pigment epithelial detachments, as well as decreased tumor thickness with an increase in internal reflectivity on ultrasound.
引用
收藏
页码:722 / 730
页数:9
相关论文
共 46 条
[31]   REGRESSION OF UVEAL MELANOMA AFTER RU-106 BRACHYTHERAPY AND THERMOTHERAPY BASED ON METABOLIC ACTIVITY MEASURED BY POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY [J].
Lee, Christopher S. ;
Lee, Sung C. ;
Lee, Kyungsik ;
Kwon, Hee J. ;
Yi, Jeong H. ;
Cho, Arthur .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (01) :182-187
[32]   A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve [J].
Maheshwari, Abhilasha ;
Finger, Paul T. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 188 :60-69
[33]   Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma [J].
Marconi, Daniel Grossi ;
de Castro, Douglas Guedes ;
Reboucas, Lievin Matos ;
Bernardes Gil, Gabriel Oliveira ;
Fogaroli, Ricardo Cesar ;
Conte Maia, Maria Aparecida ;
Gobo Silva, Maria Leticia ;
Assis Pellizzon, Antonio Cassio ;
Motono Chojniak, Maria Marta .
BRACHYTHERAPY, 2013, 12 (03) :235-239
[34]   Quantitative echography in primary uveal melanoma treated by proton beam therapy [J].
Mosci, Carlo ;
Lanza, Francesco B. ;
Mosci, Sofia ;
Barla, Annalisa .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2014, 49 (01) :60-65
[35]   Echographic findings in uveal melanomas treated with the Leksell gamma knife [J].
Müllner, K ;
Langmann, G ;
Pendl, G ;
Faulborn, J .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (02) :154-158
[36]   The American brachytherapy society recommendations for brachytherapy of uveal melanomas [J].
Nag, S ;
Quivey, JM ;
Earle, JD ;
Followill, D ;
Fontanesi, J ;
Finger, PT .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02) :544-555
[37]   Extraocular Muscle Repositioning and Diplopia Associated with Ophthalmic Plaque Radiation Therapy for Choroidal Melanoma [J].
Nagendran, Sonali T. ;
Finger, Paul T. ;
Campolattaro, Brian N. .
OPHTHALMOLOGY, 2014, 121 (11) :2268-2274
[38]  
Novak-Andrejcic K, 2003, KLIN MONATSBL AUGENH, V220, P853
[39]   Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas [J].
Papakostas, Thanos D. ;
Lane, Anne Marie ;
Morrison, Margaux ;
Gragoudas, Evangelos S. ;
Kim, Ivana K. .
JAMA OPHTHALMOLOGY, 2017, 135 (11) :1191-1196
[40]   Visual acuity, oncologic, and toxicity outcomes with 103Pd vs. 125I plaque treatment for choroidal melanoma [J].
Patel, Kirtesh R. ;
Prabhu, Roshan S. ;
Switchenko, Jeffrey M. ;
Chowdhary, Mudit ;
Craven, Caroline ;
Mendoza, Pia ;
Danish, Hasan ;
Grossniklaus, Hans E. ;
Aaberg, Thomas M., Sr. ;
Aaberg, Thomas, Jr. ;
Reddy, Sahitya ;
Butker, Elizabeth ;
Bergstrom, Chris ;
Crocker, Ian R. .
BRACHYTHERAPY, 2017, 16 (03) :646-653